Uracil DNA glycosylase is a DNA repair enzyme whose single job is to find and remove uracil bases that do not belong in DNA. Uracil is a normal building block of RNA, but when it turns up in DNA it signals damage or a copying error that, left unrepaired, can cause mutations. Discovered in 1974, uracil DNA glycosylase was the first enzyme identified in what is now called the base excision repair pathway, and it remains one of the most studied repair enzymes in molecular biology.1BioEssays. Recent progress in the biology, chemistry and structural biology of DNA glycosylases Its reach extends well beyond simple housekeeping: variants of this enzyme play roles in immune defense, viral infection, cancer biology, and modern gene-editing technology.
How Uracil Ends Up in DNA
Uracil can appear in your genome through two distinct routes. The first is spontaneous chemical damage: a cytosine base in DNA loses an amino group (a reaction called deamination) and converts directly into uracil. Because cytosine normally pairs with guanine, this creates a uracil-guanine mismatch. If the cell copies that stretch of DNA before fixing it, the uracil will pair with adenine instead, permanently swapping a G-C pair for an A-T pair. That is a point mutation, and it happens thousands of times per cell per day under normal conditions.2PubMed. Uracil in DNA–general mutagen, but normal intermediate in acquired immunity
The second route is misincorporation during DNA replication. Cells maintain a pool of nucleotide building blocks, and the uracil-containing version (dUMP) sometimes gets inserted where thymine (dTMP) should go. Studies of mouse cells lacking uracil DNA glycosylase found that the amount of uracil in their DNA climbed sharply with cell division, indicating that most of the uracil buildup came from this replication error rather than from cytosine deamination.3Carcinogenesis. Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts Unlike the deamination route, misincorporated uracil sits across from adenine, which is the same pairing thymine would form. It is not immediately mutagenic, but it can still cause problems if the repair machinery later mistakes it for damage and processes it incorrectly.
The Base-Flipping Mechanism
Uracil DNA glycosylase faces a needle-in-a-haystack problem: it has to scan billions of base pairs and pick out the rare uracils hidden among structurally similar thymine bases. The solution is a striking physical maneuver. The enzyme slides along the DNA, and when it encounters a uracil, it flips the entire nucleotide out of the double helix and into a pocket on the enzyme’s surface.4Biochemistry. Mutational Analysis of the Base-Flipping Mechanism of Uracil DNA Glycosylase Structural studies of the human enzyme show that this involves pushing a specific amino acid side chain into the DNA through the minor groove, compressing the backbone around the uracil, and essentially squeezing the damaged base out through the major groove.5PubMed. A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA
Once the uracil is flipped out, it lands in a rigid pocket at the bottom of a groove on the enzyme. This pocket is exquisitely shaped to accept uracil and reject other bases, including thymine, which differs from uracil by just a single methyl group. Hydrogen bonds from the protein backbone and a key side chain lock the uracil in place, and the enzyme then clips the bond connecting the base to the sugar-phosphate backbone.6Cell. Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: Protein mimicry of DNA What remains is an “abasic site,” a spot in the DNA with no base at all. That empty site is then handed off to the next enzyme in the repair pathway, an endonuclease that cuts the backbone so the gap can be filled with the correct nucleotide.
Two Isoforms From One Gene
In humans, a single gene called UNG encodes two versions of the enzyme: UNG1 and UNG2. They share the same catalytic core but have different front ends that act as address labels, directing each version to a different compartment of the cell. UNG1 carries a strong signal that routes it to the mitochondria, the cell’s energy-producing organelles, which have their own small genome that also needs protection from uracil. UNG2 carries a different, more complex signal that sends it to the nucleus, where the main genome resides.7PubMed Central. Nuclear and mitochondrial splice forms of human uracil-DNA glycosylase contain a complex nuclear localisation signal and a strong classical mitochondrial localisation signal, respectively
This clean division of labor was the accepted picture for years, but it turned out to be incomplete. Researchers generating cell lines that expressed only one isoform at a time discovered a variant of UNG1 that also travels to the nucleus, where it can support DNA repair and even contribute to immune functions normally attributed to UNG2.8PubMed Central. Uracil–DNA glycosylase UNG1 isoform variant supports class switch recombination and repairs nuclear genomic uracil The practical takeaway is that the cell has some built-in redundancy: losing one isoform does not necessarily leave a compartment defenseless.
The Backup Crew: Other Uracil-Removing Enzymes
UNG is the fastest and most abundant uracil-removing enzyme in dividing cells, but it is not the only one. Mammals have at least four other glycosylases that can excise uracil from DNA: SMUG1, TDG, MBD4, and to some extent the UNG1 variant mentioned above. These enzymes have overlapping but not identical preferences. SMUG1, for example, appears to be more important in cells that are not actively dividing, while TDG and MBD4 prefer uracil-guanine mismatches and have additional roles in handling other types of damaged bases.9PubMed Central. Uracil in DNA and its processing by different DNA glycosylases
SMUG1 and UNG2 coordinate the first steps of repair through different strategies. UNG2 appears to physically interact with the endonuclease that handles the abasic site, smoothly handing off the damage for the next step. SMUG1, by contrast, stays bound to the abasic site until the endonuclease arrives and displaces it.10Nucleic Acids Research. Uracil–DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms This layered system means that cells missing UNG are impaired but not helpless. The backup enzymes pick up some of the slack, though not all of it, particularly during rapid cell division when uracil accumulates fastest.
A Surprising Role in the Immune System
One of the more counterintuitive facts about uracil in DNA is that the immune system deliberately creates it. When B cells (the white blood cells responsible for producing antibodies) encounter an invading pathogen, they activate an enzyme called AID (activation-induced cytidine deaminase) that intentionally deaminates cytosines at immunoglobulin gene loci, flooding those regions with uracil. This controlled damage is what allows B cells to switch the class of antibody they produce and to fine-tune antibody binding through mutations.11PubMed. Uracil in DNA–general mutagen, but normal intermediate in acquired immunity
UNG2 plays a central role in this process. By removing the uracils that AID creates, it generates abasic sites that are then cut and processed. Depending on how the repair proceeds, the result is either a clean class switch or the introduction of further mutations that diversify the antibody repertoire. Recent work has shown that a protein called RPA helps guide UNG to the uracils in single-stranded DNA that arise during this process. Disrupting the UNG-RPA interaction impairs antibody class switching and the repair of AID-induced damage at immunoglobulin loci, but has little effect on overall genomic uracil levels, suggesting this guidance system is specifically tuned for the immune response rather than general genome maintenance.12Nucleic Acids Research. RPA guides UNG to uracil in ssDNA to facilitate antibody class switching and repair of mutagenic uracil at the replication fork
The mutagenic side of this process is not entirely benign. Some of those mutations can spill beyond the immunoglobulin loci, and the interplay between UNG2, translesion polymerases, and APOBEC family deaminases has been linked to kataegis, a pattern of clustered mutations on one DNA strand that shows up near genomic rearrangements in certain cancers.13PubMed. Error-free versus mutagenic processing of genomic uracil–relevance to cancer
UNG2 at the Replication Fork
In dividing cells, UNG2 does not just patrol finished DNA. It also stations itself at the replication fork, the moving complex where new DNA is being synthesized. To get there, UNG2 relies on physical interactions with two proteins already present at the fork: PCNA (a ring-shaped clamp that keeps the replication machinery anchored to the DNA) and the RPA protein mentioned earlier. Without these interactions, UNG2 has trouble localizing to stalled replication forks, meaning that any uracil incorporated during replication or generated nearby may go unrepaired until after the fork has moved on.14PubMed Central. Efficient activity of uracil DNA glycosylase (UNG2) in proliferating cells requires binding to proliferating cell nuclear antigen (PCNA) and replication protein A (RPA) This tight coupling between repair and replication makes sense: the fastest way to prevent a copying error from becoming permanent is to catch it while the copying machinery is still in the neighborhood.
How Viruses and Phages Fight Back
The efficiency of uracil DNA glycosylase makes it a threat to certain viruses whose replication strategies leave uracil in their DNA. Some viruses have evolved proteins specifically designed to shut the enzyme down.
The best-known natural inhibitor is Ugi, a small protein produced by the bacteriophage PBS2. Ugi works through molecular mimicry: its surface imitates the shape and charge distribution of DNA well enough to slide into UDG’s DNA-binding groove, blocking the enzyme completely. Crystal structures show that Ugi inserts one of its protein strands into the groove without ever touching the uracil-recognition pocket, essentially tricking the enzyme into thinking it has grabbed a stretch of DNA.15Cell. Crystal structure of the inhibitor of uracil-DNA glycosylase from bacteriophage PBS2 trapped in a complex with human uracil-DNA glycosylase A different phage, ϕ29, uses a structurally unrelated protein called p56 that achieves the same goal through a completely different strategy. Instead of mimicking DNA, the p56 protein forms a dimer that clamps around a protruding loop on the bacterial UDG, burying a key phenylalanine residue in a hydrophobic pocket at the dimer interface.16Nucleic Acids Research. Crystal structure and functional insights into uracil-DNA glycosylase inhibition by phage ϕ29 DNA mimic protein p56
HIV-1 takes yet another approach. Its accessory protein Vpr binds to UNG2 in human CD4+ T cells and targets it for destruction by hijacking the cell’s own protein-disposal machinery. In HIV-1-infected cells, this leads to a marked drop in UNG2 levels and a measurable loss of uracil excision activity, causing uracil to accumulate in the host cell’s genome.17PubMed Central. Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA Interestingly, HIV-2 does not degrade UNG2 the same way. The two main types of HIV appear to use entirely different strategies to protect their DNA from the host’s repair enzymes, with HIV-1 actively removing the repair proteins and HIV-2 taking an alternative route that focuses on boosting its nucleotide supply during viral DNA synthesis.18Proceedings of the National Academy of Sciences. HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins
Laboratory Workhorse for PCR Contamination Control
Long before uracil DNA glycosylase became a topic in virology or immunology, it found a second life in molecular biology labs as a tool for preventing false positives in PCR, the technique used to amplify tiny amounts of DNA. The problem it solves is “carry-over contamination”: amplified DNA fragments from a previous experiment drift into a new reaction and produce a false positive result. The fix is elegant. Researchers run their PCR reactions using dUTP instead of the normal dTTP, so that every amplified product contains uracil where thymine would normally be. Before starting a new reaction, the enzyme is added to the fully assembled mix. It destroys any uracil-containing contaminants from earlier runs by removing the uracil bases, leaving the DNA too damaged to be amplified. Because the enzyme does not attack the natural thymine-containing template, and because it is inactivated by the high temperatures of the PCR cycle itself, the target DNA is amplified normally once the reaction begins.19PubMed. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions This UNG-based decontamination method became a standard practice in clinical and forensic PCR laboratories and remains widely used.20Molecular and Cellular Probes. Use of modified nucleotides and uracil-DNA glycosylase (UNG) for the control of contamination in the PCR-based amplification of RNA
A related application has emerged in ancient DNA research. DNA extracted from very old specimens carries characteristic chemical damage, including cytosine-to-uracil conversions that accumulate over centuries. By applying a partial UDG treatment to ancient DNA libraries, researchers can restrict these damage artifacts to the ends of DNA fragments while nearly eliminating them from the interior. This allows a single library preparation to serve double duty: the end damage authenticates the sample as genuinely ancient, while the clean interior sequences are reliable enough for population genetic analysis.21PubMed. Partial uracil-DNA-glycosylase treatment for screening of ancient DNA
Uracil DNA Glycosylase Inhibitors in Gene Editing
The phage-derived Ugi protein has found an unexpected second career in CRISPR-based gene editing. Cytosine base editors are tools designed to convert a C-G base pair to a T-A pair at a precise location in the genome. They work by chemically converting a target cytosine to uracil, then relying on the cell’s own replication to read that uracil as thymine. The problem is that the cell’s uracil DNA glycosylase will often remove the uracil before replication gets there, undoing the edit. To prevent this, base editors are built with a copy of Ugi fused to the editing protein, blocking uracil removal long enough for the edit to become permanent.22PubMed Central. UGI relocation inside Cas9 reduces Cas9 dependent off target effects in cytosine base editors
Getting this balance right is an ongoing engineering challenge. Insufficient UDG inhibition means many of your intended edits get erased by the repair machinery before they stick, which has been identified as a key bottleneck for the efficiency of base editors delivered in vivo.23Nature Biotechnology. Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition Too much inhibition, or inhibition in the wrong places, and the editor starts making unwanted changes at off-target sites across the genome. One recent strategy is to move the Ugi component from its conventional position at the tail end of the Cas9 protein to an internal location within the protein’s architecture. This spatial reorganization maintains on-target editing while substantially reducing off-target activity elsewhere in the genome.24PubMed Central. UGI relocation inside Cas9 reduces Cas9 dependent off target effects in cytosine base editors
Connections to Cancer
Given that uracil DNA glycosylase sits at the intersection of DNA repair, mutagenesis, and cell division, its connection to cancer biology was inevitable. In colorectal cancer, UNG expression is significantly higher than in normal tissue, and higher UNG levels correlate with poorer patient outcomes. Laboratory experiments silencing UNG in colorectal cancer cell lines showed reduced proliferation, decreased migration and invasion, and increased cell death, suggesting the enzyme may actively support tumor growth rather than simply protecting against it.25PubMed Central. Silencing Uracil-DNA glycosylase inhibits colorectal cancer progression
This apparent paradox, a repair enzyme that helps cancers grow, makes more sense when you consider that rapidly dividing tumor cells generate enormous amounts of uracil during replication and may depend on UNG to prevent the damage from becoming lethal. That dependency creates a potential therapeutic angle. Inhibiting UNG in cancer cells can sensitize them to certain chemotherapy drugs. In a panel of colorectal cancer cell lines, blocking UNG activity with the Ugi protein made over half the lines dramatically more sensitive to the drug 5-fluorodeoxyuridine, with potency increases ranging from six- to seventy-fold.26Molecular Pharmacology. Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil Separately, researchers have proposed that inhibiting UNG and letting uracil accumulate could trigger replication stress specifically in tumors that already lack certain DNA repair pathways, offering a potential strategy for cancers deficient in homology-directed repair.27Molecular Cell. Genomic uracil and uracil-induced replication stress
A Role in Epigenetic Regulation
Beyond cleaning up straightforward damage, uracil DNA glycosylase may participate in the active removal of chemical tags that control gene expression. Cells regulate which genes are turned on or off partly by adding or removing methyl groups from cytosine bases. One route for removing these methyl marks involves a family of enzymes called Tet proteins, which oxidize methylated cytosine through several intermediate forms. Some of these intermediates can undergo deamination, producing modified uracil species. Experiments with purified UNG2 have shown that, besides its strong activity on normal uracil, the enzyme can also excise one of these intermediates (5-carboxyuracil) from DNA, suggesting it may contribute to the final steps of active DNA demethylation.28Journal of Biological Chemistry. Uracil-DNA Glycosylase UNG Promotes Tet-mediated DNA Demethylation This activity was weak compared to its normal uracil excision, and the biological importance is still being worked out, but it hints that the enzyme’s evolutionary toolkit may be broader than its name suggests.
Ancient Origins Across All Domains of Life
Uracil DNA glycosylases are not just a mammalian feature. Phylogenomic analysis shows that members of the UDG superfamily are found across all three domains of life, bacteria, archaea, and eukaryotes, indicating that these enzymes appeared very early in evolution.29Molecular Biology and Evolution. Phylogenomic Analysis of the Uracil-DNA Glycosylase Superfamily This makes sense given that cytosine deamination is a spontaneous chemical reaction driven by water and heat, problems that have existed as long as DNA-based life has. The superfamily has diversified into several structural families with different substrate preferences, but the core job of recognizing and removing uracil from DNA has been conserved for billions of years. That kind of deep evolutionary conservation is a good marker of how essential the function is: organisms that lost the ability to remove uracil from their genomes simply did not survive long enough to leave descendants.